Drug Shortage Report for ROBAXACET-8
| Report ID | 136009 |
| Drug Identification Number | 01934767 |
| Brand name | ROBAXACET-8 |
| Common or Proper name | NA |
| Company Name | HALEON CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOCARBAMOL ACETAMINOPHEN CODEINE PHOSPHATE |
| Strength(s) | 400MG 325MG 8MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-04-05 |
| Actual start date | |
| Estimated end date | 2022-08-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-07-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 450-55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-07-06 | French | Compare |
| v7 | 2022-07-06 | English | Compare |
| v6 | 2022-02-02 | French | Compare |
| v5 | 2022-02-02 | English | Compare |
| v4 | 2022-02-02 | English | Compare |
| v3 | 2021-04-06 | English | Compare |
| v2 | 2021-03-19 | French | Compare |
| v1 | 2021-03-19 | English | Compare |
Showing 1 to 8 of 8